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Objective: Periodontal disease is an inflammatory disease principally caused by a complex interaction between pathogenic bacteria and immune 
responses. Probiotics stimulate the immune system of the oral mucosa by increasing the production of anti-inflammatory cytokines. Interleukin-4 (IL-4) is 
the anti-inflammatory cytokine that is most closely associated with the pathogenesis of periodontitis. This study assessed the effect of Lactobacillus reuteri 
(L. reuteri) containing probiotic lozenges toward clinical attachment loss (CAL) and IL-4 levels in periodontitis patients after scaling and root planing. 
Materials and Methods: Clinical samples were collected from the gingival crevicular fluid of 16 periodontitis patients with pocket depth (PD) of 
6 mm. The samples were divided into two groups. The non-probiotic group included periodontitis patients treated through scaling and root planing 
(SRP) only (n=8), whereas the probiotic group included periodontitis patients treated through SRP and probiotics (n=8). The measurements of the 
clinical parameters of PD and CAL were included as diagnostic criteria. Probiotic lozenges were given daily for 14 days. IL-4 levels were measured in 
both groups using the enzyme-linked immunosorbent assay (ELISA) method.
Results: IL-4 levels decreased in the non-probiotic group and increased in the probiotic group, but there was no statistical difference between the 
groups. CAL decreased in both groups and was significantly different.
Conclusion: SRP with the consumption of probiotic-containing L.reuteri in periodontitis patients resulted in decreased CAL and increased IL-4 levels 
compared with SRP only.
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INTRODUCTION
Periodontal disease is an inflammatory disease of the periodontal tissue. It 
can destroy the periodontal ligament and alveolar bone form periodontal 
pockets, gingival recession, or combination [1]. Groups of specific 
microorganisms mainly cause periodontal diseases. An imbalance between 
pathogenic bacteria and immune responses can destroy the periodontal 
tissue [2]. Host immune response is a determining factor in the development 
of periodontal disease [3]. Periodontal treatment primarily includes scaling 
and root planing (SRP). However, in some cases, SRP is insufficient to treat 
periodontal disease. In the past 20 years, antibiotics have been administered 
as additional therapy [4]. Incorrect use of antibiotics can cause bacterial 
resistance and recolonization in the same site; therefore, a novel adjunct 
therapy needed for the periodontal disease [3].
Probiotics are living microorganisms, which can have beneficial 
health effects on the host [5]. Probiotics significantly influence the 
periodontium regarding plaque modification, halitosis management, 
changing anaerobic bacterial colonization, reducing pocket depth 
(PD), and clinical attachment loss (CAL)-associated with host cell 
responses [5]. Probiotics are broadly categorized into two genera: 
Lactobacillus and Bifidobacterium [5]. Penala et al. stated that the 
administration of Lactobacillus reuteri (L. reuteri) once daily for 14 
days can be therapy for SRP and very effective in reducing periodontal 
pocket depth (PD) [6]. A study by Waerhug et al. stated that healing 
after occurs within 2 weeks, whereby the epithelial proliferation 
process stops within 7–14 days after SRP [7].
Periodontal disease is often associated with excessive production 
of pro-inflammatory cytokines or an imbalance between the 
production of pro-inflammatory and anti-inflammatory cytokines [8]. 
Anti-inflammatory cytokines are a series of immunoregulatory molecules 
that control the cytokine pro-inflammatory response [8]. The main 
anti-inflammatory cytokines are interleukin (IL)-4, IL-10, IL-12, 
IL-13, and IL-18 [8]. Probiotics stimulate and modulate the immune 
system of the oral mucosa by reducing pro-inflammatory cytokine 
production through action on the NFkB pathway and increasing anti-
inflammatory cytokines [9]. Among the inflammatory factors, IL-4 
is the anti-inflammatory cytokine most closely associated with the 
pathogenesis of periodontitis through increasing Th2 proliferation, 
suppressing Th1 proliferation, and suppressing the Th1-mediated 
immune response [10].
Indonesia, there are many circulating probiotics in the form of 
tablets, lozenges, chewing gum, and toothpaste, but few studies on the 
effectiveness of these probiotics. A study has reported that probiotics 
containing L. reuteri can increase the secretion of anti-inflammatory 
cytokines such as IL-10 and IL-4 [11], whereas other studies have 
suggested that such probiotics are not effective against the increase in 
IL-4 [12]. This study aims to assess the effect of L .reuteri containing 
probiotic lozenges on CAL and IL-4 levels in periodontitis patients after 
SRP. We hypothesized that IL-4 levels would increase and CAL would 
decrease after SRP on consuming probiotics.
MATERIALS AND METHODS
Materials
Clinical samples were collected from patients at the Dental Teaching 
Hospital, Faculty of Dentistry, Universitas Indonesia, and laboratory 
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work was conducted in the Laboratory of IMERI at the Faculty of 
Medicine, Universitas Indonesia.
This work was based on an observational study design. Clinical samples 
were collected from the gingival crevicular fluid (GCF) of 16 individuals 
(aged 20–56 years) between May and June 2019. All subjects gave 
written informed consent to participate in this study. Complete 
anamnesis was done by asking the chief complaint, medical history, 
allergies, systemic conditions, medications, smoking habits, and tooth 
brushing habits.
Detailed information was obtained by checking their oral cavity, 
measuring their oral hygiene index, PD, recession, and CAL. Inclusion 
criteria were subjects with periodontitis stages II, III, and IV, according 
to the World Workshop on the Classification of Periodontal and Peri-
Implant Diseases and Conditions 2017 [13]. Clinical parameters 
included pocket depth (PD) (=6 mm), PBI, and CAL (≥1 mm). Exclusion 
criterias were: A history of systemic disease, bruxism or smoking, 
intake of antibiotics within the previous 3 months, pregnancy or 
breastfeeding, and scaling or other periodontal treatment ≤6 months.
Methods
Clinical samples in the non-probiotic dan the probiotic groups were 
determined randomly. Periodontal clinical examination for PD was 
recorded using the Periodontal Probe UNC 15 (Osung Mnd, Korea). 
After the examination, a sample of GCF was collected from each 
individual before SRP. GCF was obtained from patients in both groups 
that had deep pockets (PD=6 mm) in randomly selected sites of the 
healthy periodontal sulcus (0–3 mm). No probiotics were given in the 
non-probiotic group, whereas the probiotic group was given probiotics 
lozenges containing L. reuteri DSM 17938 daily for 14 d, which were 
marketed in Indonesia. Probiotic were given blindly. After 14 days, 
GCF was collected again from each individual in both groups. GCF was 
extracted to measure IL-4 levels using the ELISA Kit (Elabscience).
This study was approved by the Ethical Committee of Dental Research 
(KEPKG), Faculty of Dentistry, Universitas Indonesia (protocol number: 
090430419).
Wilcoxon test was used for comparing IL-4 levels in the non-probiotic 
and the probiotic groups before and after SRP. Wilcoxon test was also 
used to conduct statistical analysis of CAL in the non-probiotic and the 
probiotic group. Data were analyzed using Statistical Package for the 
Social Sciences 23.0.
RESULTS AND DISCUSSION
Fig. 1 shows the average of IL-4 levels increased in the probiotic group 
but decreased in the non-probiotic group and Fig. 2 shows the average 
of CAL decreased in both groups.
The results of statistical analysis of IL-4 levels in both groups with 
abnormal data distribution using the Wilcoxon test method were 
not significantly different (pnon-probiotic = 0.17 and pprobiotic = 0.139). CAL 
was significantly different in non-probiotic and probiotic groups 
(pnon-probiotic = 0.004 and pprobiotic = 0.004) (Table 1). 
The host immune response has an important role in damaging 
connective tissue and bone [14]. Probiotics increase the host immune 
response [15]. IL-4, a potent down regulator of macrophage function, 
can inhibit the secretion of pro-inflammatory cytokines such as IL-1, 
IL-6, and TNF-α to prevent periodontitis [15].
This study found that IL-4 levels in periodontitis patients increased 
after 14 days of SRP with probiotics, and IL-4 levels in periodontitis 
patients decreased after 14 days of SRP only. The decrease in IL-4 
levels is caused by incomplete wound healing. The wound healing 
process is divided into phases: The inflammatory phase, the 
proliferation phase, and the maturation and remodeling phase [15]. 
The proliferation phase consists of granulation tissue formation, 
reepithelization, and neovascularization. Reepithelization occurs on 
the 14th day, and IL-4 levels continue to decline until the 19th day [16]. 
This is inconsistent with the results of the research by Warung et al. 
and Penala et al., which states that there is a healing of the pocket 
within 14 days. Increased levels of IL-4 in periodontitis patients who 
received SRP with probiotics showed that the probiotic L. reuteri 
accelerates the healing process [17]. This is consistent with the 
results of a study by Poutahidis et al., which states that probiotics 
increase the production of oxytocin which can accelerate the healing 
process [17].
Table 1: CAL and IL-4 levels in the non-probiotic and the probiotic groups`
Before SRP After SRP p
Mean±SD Med (Min-Max) Mean±SD Med (Min-Max)
Non-probiotic CAL (mm) 6.70±0.82 6.50 (6.00-8.00) 4.70±0.67 5.00 (4.00–6.00) 0.004*
IL-4 level (pg/mL) 12.02±4.42 11.70 (5.68–18.79) 6.45±2.56 5.68 (4.34–13.24) 0.17
Probiotic CAL (mm) 6.70±0.82 6.50 (6.00–8.00) 3.90±1.37 4.00 (2.00–6.00) 0.004*
IL-4 level (pg/mL) 14.39±11.42 10.60 (4.1–39.85) 19.52±8.69 20.23 (7.96–35.23) 0.139
SD: Standard deviation; *Significant difference (Wilcoxon test, p<0.05)
Fig. 2: The average of CAL in the Non-probiotic and the probiotic 
groups
Fig. 1: The Average of IL-4 levels in the Non-probiotic and the 
probiotic groups
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Probiotics can also prevent periodontal disease [18]. Periodontal 
pocket shallowing in periodontitis patients may happen as a result 
of SRP and the administration of probiotics. Periodontal pocket 
shallowing can cause a reduction in CAL [18]. SRP can eliminate 
bacteria as the main cause of periodontitis. Lactic acid produced 
from probiotics can penetrate the bacterial membrane and acidify 
the cytoplasm by inhibiting the proliferation of periodontal 
disease-causing bacteria such as Porphyromonas gingivalis and 
Prevotella intermedia [18]. Reuterin, a bacteriocin produced by 
L .reuteri, has antibacterial activity against Gram-negative bacteria 
that cause periodontal disease [18].
IL-4 levels in the non-probiotic and the probiotic group before and 
after SRP were not significantly different. It should also be considered 
that saliva composition, including its inflammatory mediators’ content, 
naturally varies in different individuals and is affected by several factors 
and conditions. As for this study, the inconclusive results reported could 
be a result of the wide range of the subjects’ age, poor compliance of 
the subjects in the treatment group regarding probiotic consumption, 
and the relatively short sampling time (14 days) after treatment in both 
groups.
CONCLUSION
SRP is the main therapy for periodontitis. This study revealed that 
consumption of L. reuteri-containing probiotic lozenges alongside SRP 
in periodontitis patients resulted in decreased CAL and increased IL-4 
levels compared with SRP only. Further studies are needed to address 
the changes in IL-4 levels in the course of periodontitis, and the effect of 
L. reuteri on oral health in humans.
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